News
BiOLOVE's Chia-Wei Kao Wins the ASPIRE 2026 Young Investigator Award
Recognised for research integrating blastocyst morphology and oocyte age to predict embryo euploidy, presented in an oral session in Beijing.
Fertility Is Corporate Vitality — BiOLOVE Speaks on Fertility-Friendly Workplaces at the 2026 CHRO Forum
EVP of R&D and Operations Chih-Yuan Hsieh brings a reproductive medicine perspective to how companies can build fertility support into talent strategy.
Leading a New Era of Smart Reproductive Medicine — Meet BiOLOVE at ASPIRE 2026
7–10 May at the China National Convention Center in Beijing, booth No. C14, with the first public showing of the HiSA smart clinical management platform.
Navigating the AI Era — BiOLOVE Joins the 2026 CHRO Forum on Talent Sustainability
29 April, 09:30–16:50, International Conference Hall, NYCU Guangfu Campus, Hsinchu. EVP of R&D and Operations Chih-Yuan Hsieh delivers a keynote.
Stories still to be written
Directions are set but the copy is not written: JSFI on 30 July, TSRM on 28 August, the ESG tree planting, the public lecture, and the opening of the Tokyo office. The home page always shows the three most recent.